UPDATE: Summer Street Initiates Lpath Incorporated at Buy on Valuation

Loading...
Loading...
Summer Street initiated coverage on Lpath Incorporated
LPTN
with a Buy rating and an $18 price target. Summer Street noted, "Lpath's valuation is compelling when compared to other platform companies in similar positions. Our iSONEP royalty projections begin in 2017 at $28MM and grow to $692MM in 2021, despite sharing the frontline market opportunity with a potential anti-PDGF inhibitor. By only including a portion of the frontline AMD market with VEGF inhibitors and the initial market refractory anti-VEGF agent failures, our model may be overly conservative." Lpath Incorporated closed at $4.90 on Wednesday.
Posted In: Analyst ColorInitiationIntraday UpdateAnalyst Ratingssummer street
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...